Effects of TGF-β1 gene on transplanting rejection in high-risk keratoplasty

LianHong Zhou,Xiangxiang Zhu,Yiqiao Xing,Jinquan Tan,Jiong Wang
DOI: https://doi.org/10.3760/cma.j.issn.2095-0160.2009.09.001
2009-01-01
Abstract:Objective: Present study was to investigate the expression of TGF-β1 gene transferred by recombinated adenoassociated virus(rAAV) in the implant tablets after high-risk keratoplasty of rats and the effects of TGF-β, gene on transplant rejection. Methods: Corneal neovascularization models were created by putting the filter paper with 1% NaCl solution in the central cornea for 20 seconds in 40 Sprague-Dawley(SD) rats. The penetrating corneal transplatation was performed in the model rats with 20 Wistar rats as donors and models as receiptors. The right eyes of 20 model rats received the grafts cultured in DMEM/F12 medium with rAAV-TGF-β1 experimental group, and another right eyes of 20 model rats received the grafts cultured in only DMEM/F12 medium as control group. After the operation, survival of grafts was examined under the slit lamp once a day at the first week and afterthere at two-day interval. The grafts rejection was scored according to Plskova criteria. Expression of TGF-β1 in graft was detected in different time points by immunohistochemistry and Western-blotting in 1 week, 2, 4 and 8 weeks after the operation. The use of the animals followed the Standard of Statement of ARVO. Results: The mean graft rejection time was (17.60 ± 2.31) days in experimental group and (9.27 ± 1.50) days in control group, showing a statistically significant difference between them (t = 6.76, P < 0.01). The degree of vascularizing and the turbidity of graft in treatment group was significantly lower than that the control group with the statistically significant difference between them (P < 0.01). TGF-β1 showed a weak expression only in corneal epithelium in the initial week and positive expression in whole layer of cornea from 2 weeks through 4 weeks in experimental group. After 2-4 weeks, TGF-β1 expression in graft was stronger in experimental group compared with control group. In the first week after operation, no significant difference in TGF-β1 expression between two groups(t = 0.46, P > 0.05). However, the TGF-β, content in grafts was significantly higher in experimental group than control group from 2 through 8 weeks after operation (P < 0.05). Conclusion: The rAAV-TGF-β1 can reduce high-risk corneal transplant rejection.
What problem does this paper attempt to address?